Acetylenic TACE inhibitors. Part 2: SAR of six-membered cyclic sulfonamide hydroxamates.
Levin, J.I., Chen, J.M., Laakso, L.M., Du, M., Du, X., Venkatesan, A.M., Sandanayaka, V., Zask, A., Xu, J., Xu, W., Zhang, Y., Skotnicki, J.S.(2005) Bioorg Med Chem Lett 15: 4345-4349
- PubMed: 16084720
- DOI: https://doi.org/10.1016/j.bmcl.2005.06.072
- Primary Citation of Related Structures:
1ZXC - PubMed Abstract:
The SAR of a series of potent sulfonamide hydroxamate TACE inhibitors bearing a butynyloxy P1' group was explored. In particular, compound 5k has excellent in vitro potency against TACE enzyme and in cells, and oral activity in an in vivo model of TNF-alpha production and a collagen-induced arthritis model.
Organizational Affiliation:
Wyeth Research, 401N. Middletown Road, Pearl River, NY 10965, USA. levinji@wyeth.com